FDA Inspection 1214801 — Zhejiang Xianju Pharmaceutical Co., Ltd. (Yangfu API).
The FDA completed an inspection of Zhejiang Xianju Pharmaceutical Co., Ltd. (Yangfu API). on July 20, 2023 in Xianju. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 20, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xianju (China)